Federated Hermes’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,756
| Closed | -$1.61M | – | 2248 |
|
|
2023
Q2 | $1.61M | Sell |
15,756
-941
| -6% | -$95.9K | ﹤0.01% | 1027 |
|
|
2023
Q1 | $1.52M | Buy |
+16,697
| New | +$1.52M | ﹤0.01% | 1048 |
|
|
2020
Q2 | – | Sell |
-3,023
| Closed | -$436K | – | 2407 |
|
|
2020
Q1 | $436K | Sell |
3,023
-48,588
| -94% | -$7.01M | ﹤0.01% | 1417 |
|
|
2019
Q4 | $10.6M | Buy |
51,611
+8,576
| +20% | +$1.75M | 0.02% | 585 |
|
|
2019
Q3 | $3.46M | Sell |
43,035
-4,419
| -9% | -$355K | 0.01% | 862 |
|
|
2019
Q2 | $4.48M | Sell |
47,454
-55,362
| -54% | -$5.22M | 0.01% | 816 |
|
|
2019
Q1 | $8.79M | Buy |
+102,816
| New | +$8.79M | 0.02% | 614 |
|
|
2018
Q4 | – | Sell |
-59,501
| Closed | -$4.87M | – | 2344 |
|
|
2018
Q3 | $4.87M | Buy |
+59,501
| New | +$4.87M | 0.01% | 814 |
|